Profile | GDS5420 / 240128_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 848.36 | 76 |
GSM1296119 | B_lesional_pre-dose | 716.03 | 74 |
GSM1296076 | C_lesional_pre-dose | 451.98 | 67 |
GSM1296092 | D_lesional_pre-dose | 344.96 | 62 |
GSM1296103 | E_lesional_pre-dose | 948.65 | 78 |
GSM1296078 | F_lesional_pre-dose | 371.74 | 64 |
GSM1296107 | G_lesional_pre-dose | 699.4 | 74 |
GSM1296109 | H_lesional_pre-dose | 799.58 | 76 |
GSM1296080 | I_lesional_pre-dose | 449.95 | 66 |
GSM1296090 | J_lesional_pre-dose | 355.59 | 63 |
GSM1296074 | K_lesional_pre-dose | 440.74 | 67 |
GSM1296111 | L_lesional_pre-dose | 602.91 | 71 |
GSM1296099 | M_lesional_pre-dose | 694.9 | 73 |
GSM1296086 | O_lesional_pre-dose | 327.3 | 61 |
GSM1296117 | P_lesional_pre-dose | 634.84 | 72 |
GSM1296113 | Q_lesional_pre-dose | 970.58 | 79 |
GSM1296096 | R_lesional_pre-dose | 696.42 | 73 |
GSM1296105 | S_lesional_pre-dose | 596.97 | 70 |
GSM1296098 | T_lesional_pre-dose | 1180.09 | 82 |
GSM1296101 | U_lesional_pre-dose | 1065.49 | 80 |
GSM1296121 | V_lesional_pre-dose | 752.33 | 75 |
GSM1296088 | W_lesional_pre-dose | 577.65 | 70 |
GSM1296082 | X_lesional_pre-dose | 438.37 | 66 |
GSM1296115 | Y_lesional_pre-dose | 699.8 | 73 |
GSM1296084 | Z_lesional_pre-dose | 559.59 | 70 |
GSM1296072 | B_lesional_day8 | 769.73 | 75 |
GSM1296069 | L_lesional_day8 | 684.16 | 73 |
GSM1296071 | P_lesional_day8 | 718.46 | 74 |
GSM1296070 | Y_lesional_day8 | 750.92 | 75 |
GSM1296073 | V_lesional_day8 | 782.52 | 75 |
GSM1296034 | A_lesional_day15 | 1235.6 | 83 |
GSM1296041 | G_lesional_day15 | 641.68 | 72 |
GSM1296035 | R_lesional_day15 | 712.13 | 73 |
GSM1296038 | U_lesional_day15 | 676.54 | 73 |
GSM1296047 | B_lesional_day15 | 785.07 | 75 |
GSM1296039 | E_lesional_day15 | 614.12 | 72 |
GSM1296042 | H_lesional_day15 | 739.26 | 74 |
GSM1296043 | L_lesional_day15 | 742.73 | 74 |
GSM1296037 | M_lesional_day15 | 707.58 | 73 |
GSM1296046 | P_lesional_day15 | 742.96 | 74 |
GSM1296044 | Q_lesional_day15 | 883.48 | 77 |
GSM1296045 | Y_lesional_day15 | 781.84 | 75 |
GSM1296025 | C_lesional_day15 | 326.15 | 61 |
GSM1296033 | D_lesional_day15 | 488.87 | 67 |
GSM1296027 | I_lesional_day15 | 327.51 | 61 |
GSM1296032 | J_lesional_day15 | 474.58 | 66 |
GSM1296024 | K_lesional_day15 | 437.4 | 66 |
GSM1296031 | W_lesional_day15 | 623.63 | 71 |
GSM1296028 | X_lesional_day15 | 402.58 | 64 |
GSM1296029 | Z_lesional_day15 | 508.46 | 68 |
GSM1296026 | F_lesional_day15 | 317.75 | 61 |
GSM1296030 | O_lesional_day15 | 372.09 | 63 |
GSM1296040 | S_lesional_day15 | 763.41 | 74 |
GSM1296036 | T_lesional_day15 | 1269.78 | 83 |
GSM1296048 | V_lesional_day15 | 794.25 | 76 |
GSM1296059 | A_lesional_day43 | 813.52 | 76 |
GSM1296066 | G_lesional_day43 | 765.75 | 75 |
GSM1296060 | R_lesional_day43 | 692.7 | 73 |
GSM1296063 | U_lesional_day43 | 652.37 | 72 |
GSM1296064 | E_lesional_day43 | 688.7 | 73 |
GSM1296067 | H_lesional_day43 | 797.73 | 75 |
GSM1296062 | M_lesional_day43 | 899.3 | 77 |
GSM1296068 | Q_lesional_day43 | 739.65 | 74 |
GSM1296050 | C_lesional_day43 | 355.6 | 62 |
GSM1296057 | D_lesional_day43 | 586.29 | 70 |
GSM1296052 | I_lesional_day43 | 366.27 | 63 |
GSM1296054 | J_lesional_day43 | 576.54 | 70 |
GSM1296049 | K_lesional_day43 | 522.74 | 68 |
GSM1296055 | W_lesional_day43 | 585.78 | 70 |
GSM1296053 | X_lesional_day43 | 668.21 | 72 |
GSM1296058 | Z_lesional_day43 | 668.27 | 72 |
GSM1296051 | F_lesional_day43 | 393.37 | 64 |
GSM1296056 | O_lesional_day43 | 526.86 | 69 |
GSM1296065 | S_lesional_day43 | 601.04 | 71 |
GSM1296061 | T_lesional_day43 | 1158.44 | 81 |
GSM1296095 | A_non-lesional_pre-dose | 736.81 | 74 |
GSM1296120 | B_non-lesional_pre-dose | 747.85 | 75 |
GSM1296077 | C_non-lesional_pre-dose | 284.12 | 59 |
GSM1296093 | D_non-lesional_pre-dose | 582.04 | 70 |
GSM1296104 | E_non-lesional_pre-dose | 576.67 | 70 |
GSM1296079 | F_non-lesional_pre-dose | 279.05 | 59 |
GSM1296108 | G_non-lesional_pre-dose | 730.56 | 74 |
GSM1296110 | H_non-lesional_pre-dose | 898.44 | 78 |
GSM1296081 | I_non-lesional_pre-dose | 314.49 | 60 |
GSM1296091 | J_non-lesional_pre-dose | 320.53 | 61 |
GSM1296075 | K_non-lesional_pre-dose | 441.2 | 66 |
GSM1296112 | L_non-lesional_pre-dose | 787.05 | 75 |
GSM1296100 | M_non-lesional_pre-dose | 583.19 | 70 |
GSM1296087 | O_non-lesional_pre-dose | 299.91 | 60 |
GSM1296118 | P_non-lesional_pre-dose | 733.9 | 74 |
GSM1296114 | Q_non-lesional_pre-dose | 1011.41 | 80 |
GSM1296097 | R_non-lesional_pre-dose | 506.32 | 68 |
GSM1296106 | S_non-lesional_pre-dose | 777.85 | 75 |
GSM1296102 | U_non-lesional_pre-dose | 881.35 | 77 |
GSM1296122 | V_non-lesional_pre-dose | 617.31 | 71 |
GSM1296089 | W_non-lesional_pre-dose | 591.9 | 70 |
GSM1296083 | X_non-lesional_pre-dose | 362.84 | 62 |
GSM1296116 | Y_non-lesional_pre-dose | 800.45 | 76 |
GSM1296085 | Z_non-lesional_pre-dose | 395.08 | 63 |